New eczema drug shows promise in Mid-Stage trial
NCT ID NCT06700499
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new drug, AK120, in 450 adults with moderate to severe atopic dermatitis (eczema). The main goal was to check for side effects and see how well the drug works. Researchers measured changes in eczema severity using standard skin scores.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Affiliated Hangzhou First People's Hospital
Hangzhou, Zhejiang, China
-
Affiliated Hospital of Chengde Medical University
Chengde, Hebei, China
-
Affiliated Hospital of Jiangsu University
Zhenjiang, Jiangsu, China
-
Affiliated Hospital of Nantong University
Nantong, Jiangsu, China
-
Anyang District Hospital
Anyang, Henan, China
-
Beijing Luhe Hospital Affiliated to Capital Medical University
Beijing, Beijing Municipality, China
-
Cangzhou People's Hospital
Cangzhou, Hebei, China
-
Changde First People's Hospital
Changde, Hunan, China
-
Guangdong Provincial Dermatology Hospital
Guangzhou, Guangdong, China
-
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, China
-
Hangzhou Third People's Hospital
Hangzhou, Zhejiang, China
-
Jiaxing Second Hospital
Jiaxing, Zhejiang, China
-
Jingzhou Central Hospital
Jingzhou, Hubei, China
-
Liuzhou People's Hospital
Liuzhou, Guangxi, China
-
Ningbo No.2 Hospital
Ningbo, Zhejiang, China
-
Peking University Third Hospital
Beijing, Beijing Municipality, China
-
People Hospital of Xingtai
Xingtai, Hebei, China
-
Qilu Hospital of Shandong University
Jinan, Shandong, China
-
Qujing No.1 Hospital
Qujing, Yunnan, China
-
Renmin Hospital of Wuhan University
Wuhan, Hubei, China
-
Sanmenxia Central Hospital
Sanmenxia, Henan, China
-
Second people's Hospital of Shenzhen
Shenzhen, Guangdong, China
-
Shandong First Medical University Affiliated Dermatology Hospital
Jinan, Shandong, China
-
Shanghai Skin Disease Hospital
Shanghai, Shanghai Municipality, China
-
Shanghai Yueyang Integrated Traditional Chinese Medicine and Western Medicine Hospital
Shanghai, Shanghai Municipality, China
-
Shenzhen Hospital of University of Hong Kong
Shenzhen, Guangdong, China
-
Shijiazhuang Hospital of Traditional Chinese Medicine
Shijiazhuang, Hebei, China
-
Sichuan Provincial People's Hospital
Chengdu, Sichuan, China
-
Taiyuan Central Hospital
Taiyuan, Shanxi, China
-
Taizhou Central Hospital
Taizhou, Zhejiang, China
-
The Affiliated Hospital of Inner Mongolia Medical College
Hohhot, Inner Mongolia, China
-
The Affiliated Hospital of Yanbian University Yanbian Hospital
Yanbian, Jilin, China
-
The First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, China
-
The First Affiliated Hospital of Kunming Medical University
Kunming, Yunnan, China
-
The First Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
-
The First Hospital of Jiaxing
Jiaxing, Zhejiang, China
-
The Second Affiliated Hospital of Henan University of Science and Technology
Luoyang, Henan, China
-
The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Tianjin, Tianjin Municipality, China
-
The Second Affiliated Hospital of Xiamen Medical College
Xiamen, Fujian, China
-
The Second Affiliated Hospital of Xingtai Medical College
Xingtai, Hebei, China
-
The Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
-
The Second Hospital & Clinical Medical School, Lanzhou University
Lanzhou, Gansu, China
-
Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital
Tianjin, Tianjin Municipality, China
-
Wuhan No.1 Hospital
Wuhan, Hubei, China
-
Wuxi People's Hospital
Wuxi, Jiangsu, China
-
XiangYa Hospital CentralSouth University
Changsha, Hunan, China
-
Xinjiang Uygur Municipal People's Hospital
Ürümqi, Xinjiang, China
-
Xiyuan Hospital of CACMS
Beijing, Beijing Municipality, China
-
Yantai Yuhuangding Hospital
Yantai, Shandong, China
-
Yueyang Central Hospital
Yueyang, Hunan, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new injection calm severe eczema when creams fall short?
- Can a new biologic calm severe eczema?
- Can a daily probiotic soothe colicky babies and calm eczema?
- Can a new injection match an existing eczema treatment?
- Can Real-World data unlock better skin disease care?
- Can a meditation app soothe teen eczema?